Sinopharm Group Co., Ltd. provided earnings guidance for the quarter ending 31 March 2020. Based on the current financial and operating information of the Group as well as the external market environment and the stage of the epidemic, the Board anticipates that the Group's performance for the first quarter ending 31 March 2020 may decline significantly on a year-on-year basis.